Back to Search
JOHN BORLAND, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1093108706Individual
Specialties, Licenses & Credentials
Research & Publications (9)
Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries.
PMID 15792927·Vascul Pharmacol·2005
4-observational
Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery.
PMID 11156120·Ann Thorac Surg·2000
8-other
Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects.
PMID 18056271·Antimicrob Agents Chemother·2008
2-rct
Safety and pharmacokinetics of GSK364735, a human immunodeficiency virus type 1 integrase inhibitor, following single and repeated administration in healthy adult subjects.
PMID 17923489·Antimicrob Agents Chemother·2007
3-trial
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
PMID 17517848·Antimicrob Agents Chemother·2007
3-trial
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.
PMID 16639341·J Acquir Immune Defic Syndr·2006
8-other
Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.
PMID 16638741·J Clin Pharmacol·2006
3-trial
Chymase-dependent angiotensin II formation in human blood vessels.
PMID 10878697·J Hum Hypertens·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1831 COMMERCE ST, SUITE 104
CORONA, CA 92880 - Phone
- (951) 737-2355
Quick Facts
- NPI
- 1093108706
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile